Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (5): 473-477.doi: 10.3736/jcim20080508

• Original Clinical Research • Previous Articles     Next Articles

Effects of low-protein diet plus α-keto acid on micro-inflammation and the relationship between micro-inflammation and nutritional status in patients performing continuous ambulatory peritoneal dialysis: a randomized controlled trial

Wei Chen, Zhi-yong Guo(), Hao Wu, Li-jing Sun, Li-li Cai, Hai-yan Xu   

  1. Department of Nephrology, Changhai Hospital, Second Military Medical University, Shanghai 200433, China
  • Received:2008-03-14 Online:2008-05-20 Published:2008-05-15
  • Contact: GUO Zhi-yong

Objective: To investigate the effects of the combination of α-keto acid and low-protein diet on the levels of serum cytokines in patients performing continuous ambulatory peritoneal dialysis (CAPD) and to explore the relationship between inflammation and malnutrition in CAPD patients.
Methods: Eighty-nine CAPD patients were randomized into three groups, and 78 cases completed a one-year follow-up and with complete data. There were 31 cases in low-protein diet plus α-keto acid group, 26 cases in low-protein diet group and 21 cases in routine-protein diet group. The levels of serum albumin (Alb), prealbumin (PA), retinol-binding protein (RBP), transferrin (TRF), cholesterol (TC), triglycerides (TG), leptin, and triceps skinfold thickness (TSF), mid-arm muscle circumference (MAMC), body mass index (BMI) were measured. The changes of serum interleukin-1α (IL-1α), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and C-reactive protein (CRP) were also detected.
Results: Compared with low-protein diet group, serum levels of PA, RBP and TRF were significantly increased both in low-protein diet plus α-keto acid and routine-protein diet groups (P<0.01), however, there was no significant difference in the levels of PA, RBP and TRF between low-protein diet plus α-keto acid group and routine-protein diet group. There was an increased tendency in the content of Alb, TC, TG, BMI, TSF and MAMC, but there were no significant differences. The plasma levels of IL-1α, IL-6 and TNF-α in low-protein diet plus α-keto acid group were decreased as compared with the routine-protein diet group, but there were no significant differences. The plasma level of CRP in low-protein diet plus α-keto acid group was lower than that in the routine-protein diet group (P<0.01).
Conclusion: The combination of α-keto acid and low-protein diet can ameliorate malnutrition and micro-inflammation in CAPD patients.

Key words: low-protein diet, keto-acids, peritoneal dialysis, inflammation, malnutrition

CLC Number: 

  • R459.51

Table 1

General data in three groups"

Baseline data Routine-protein diet
Low-protein diet
Low-protein diet plus α-keto acid
Age ($\bar{x}$±s, years) 68.7±15.9 64.1±10.7 67.2±12.5
Male/Female 12/9 15/11 18/13
Duration of peritoneal dialysis($\bar{x}$±s,months) 34.7±19.6 29.5±20.1 31.3±24.8
Diabetic patient (%) 19.0 (4/21) 11.5 (3/26) 16.1 (5/31)
BMI ($\bar{x}$±s, kg/m2) 25.36±6.13 22.14±2.19 23.97±3.02
Urine volume ($\bar{x}$±s, ml/d) 993±289 1 190±478 1 067±325
BUN ($\bar{x}$±s, mmol/L) 14.07±5.33 13.41±6.76 11.23±5.91
SCr ($\bar{x}$±s, μmol/L) 845.52±120.87 812.46±157.91 782.09±211.37
Amino acids ($\bar{x}$±s, mg/L) 359.0±143.5 341.7±115.4 353.2±141.9
Energy intake [$\bar{x}$±s, kcal/(kg·d)] 1 709±1 045 1 671±723 1 878±821
nPNA [$\bar{x}$±s, g/(kg·d)] 1.03±0.35 0.77±0.21 0.81±0.19
Alb ($\bar{x}$±s, g/L) 35.7±6.3 33.1±4.5 34.1±6.1
PA ($\bar{x}$±s, mg/L) 178.1±81.9 191.4±69.6 181.5±73.2
Urea Kt/V ($\bar{x}$±s) 1.78±0.33 1.81±0.21 1.85±0.56
Ccr [x±s, L/(week·1.73 m2)] 85.2±17.7 83.4±16.9 87.3±21.2
EPO dosage ($\bar{x}$±s, kU/week) 6.02±1.98 6.13±2.16 6.08±2.01
TC ($\bar{x}$±s, mmol/L) 4.56±1.84 4.34±1.11 4.98±1.23
TG ($\bar{x}$±s, mmol/L) 1.48±0.61 1.21±0.40 1.32±0.56
TSF ($\bar{x}$±s, mm) 23.10±5.67 20.44±6.02 22.77±7.12
MAMC ($\bar{x}$±s, mm) 20.11±2.78 18.21±3.26 19.34±2.15
RBP ($\bar{x}$±s, mg/L) 16.4±8.2 18.4±7.1 17.2±9.7
TRF ($\bar{x}$±s, mg/L) 1.79±1.34 1.67±0.56 1.41±1.34
Leptin ($\bar{x}$±s, μg/L) 51.1±17.3 49.3±19.1 53.2±19.4

Table 2

(to be continued) Changes of nutritional status in CAPD patients before and after treatment in three groups ($\bar{x}$±s)"

Group n BMI (kg/m2) SCr (μmol/L) Alb (g/L) TC (mmol/L) TG (mmol/L)
Routine-protein diet
Pre-treatment 21 25.36±6.13 845.52±120.87 35.7±6.3 4.56±1.84 1.48±0.61
Post-treatment 21 27.03±7.78 879.23±112.84**△△ 37.2±7.7 5.71±2.21 1.83±0.92
Low-protein diet
Pre-treatment 26 22.14±2.19 812.46±157.91 33.1±4.5 4.34±1.11 1.21±0.40
Post-treatment 26 24.12±4.39 714.61±145.09 34.1±6.5 4.96±1.61 1.53±0.56
Low-protein diet plus α-keto acid
Pre-treatment 31 23.97±3.02 782.09±211.37 34.1±6.1 4.98±1.23 1.32±0.56
Post-treatment 31 25.86±5.23 838.17±216.83**△△ 36.4±7.7 5.35±1.40 1.72±0.78
Group n TSF (mm) MAMC (mm) RBP (mg/L) PA (mg/L) TRF (mg/L) Leptin (μg/L)
Routine-protein diet
Pre-treatment 21 23.10±5.67 20.11±2.78 16.4±8.2 178.1±81.9 1.79±1.34 51.1±17.3
Post-reatment 21 25.11±7.24 23.22±4.90 33.3±12.1** 291.4±101.6** 3.98±1.55** 33.1±27.1**
Low-protein diet
Pre-treatment 26 20.44±6.02 18.21±3.26 18.4±7.1 191.4±69.6 1.67±0.56 49.3±19.1
Post-reatment 26 22.80±7.10 20.17±3.37 19.1±5.9 210.4±91.9 1.92±0.73 47.9±31.5
Low-protein diet plus α-keto acid
Pre-treatment 31 22.77±7.12 19.34±2.15 17.2±9.7 181.5±73.2 1.41±1.34 53.2±19.4
Post-reatment 31 24.78±8.16 21.34±3.58 31.8±11.7** 282.7±87.2** 3.11±1.14** 37.5±27.1**

Table 3

Changes of serum inflammation cytokines in CAPD patients before and after treatment in three groups ($\bar{x}$±s)"

Group n IL-1α (ng/L) IL-6 (ng/L) TNF-α (ng/L) CRP (mg/L)
Routine-protein diet
Pre-treatment 21 36.09±13.19 11.99±1.43 167.55±62.65 17.88±10.79
Post-treatment 21 31.56±13.33 7.08±2.81 123.40±10.99 9.12±5.08**
Low-protein diet
Pre-treatment 26 37.33±9.77 11.02±3.79 140.78±43.09 19.51±7.33
Post-treatment 26 35.64±10.78 9.34±4.56 129.02±59.55 16.21±2.39
Low-protein diet plus α-keto acid
Pre-treatment 31 39.41±11.23 12.67±7.21 154.89±78.11 15.76±4.45
Post-treatment 31 33.40±12.81 8.19±6.35 117.78±56.77 8.80±3.67**
[1] Moshyedi AK, Josephs MD, Abdalla EK , et al. Increased leptin expression in mice with bacterial peritonitis is partially regulated by tumor necrosis factor alpha[J]. Infect Immun, 1998,66(4):1800-1802
[2] Teplan V, Schück O, Knotek A , et al. Effects of low-protein diet supplemented with ketoacids and erythropoietin in chronic renal failure: a long-term metabolic study[J]. Ann Transplant, 2001,6(1):47-53
[3] Zimmermann J, Herrlinger S, Pruy A , et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients[J]. Kidney Int, 1999,55(2):648-658
doi: 10.1046/j.1523-1755.1999.00273.x pmid: 9987089
[4] Stenvinkel P, Heimbürger O, Paultre F , et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure[J]. Kidney Int, 1999,55(5):1899-1911
doi: 10.1046/j.1523-1755.1999.00422.x
[5] Kaizu Y, Ohkawa S, Odamaki M , et al. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients[J].Am J Kidney Dis, 2003, 42: 295-302
doi: 10.1016/S0272-6386(03)00654-1 pmid: 12900811
[6] Kaizu Y, Kimura M, Yoneyama T , et al. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients[J]. Am J Kidney Dis, 1998,31(1):93-100
doi: 10.1053/ajkd.1998.v31.pm9428458 pmid: 9428458
[7] Bergstr?m J, Lindholm B, Lacson E Jr , et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?[J]. Semin Dial, 2000,13(3):163-175
[8] McCusker FX, Teehan BP, Thorpe KE , et al.How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA( CANUSA) Peritoneal Dialysis Study Group[J].Kidney Int Suppl, 1996, 56: S56-S61
[9] Panichi V, Migliori M, De Pietro S , et al.The link of biocompatibility to cytokine production[J].Kidney Int Suppl, 2000, 58: 96-103
doi: 10.1046/j.1523-1755.2000.07612.x
[10] Yeun JY, Kaysen GA . Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients[J]. Am J Kidney Dis, 1997,30(6):923-927
doi: 10.1016/S0272-6386(97)90105-0
[1] Keat Lam Ho, Phaik Har Yong, Chee Woon Wang, Umah Rani Kuppusamy, Chek Tung Ngo, Festo Massawe, Zhi Xiang Ng. Peperomia pellucida (L.) Kunth and eye diseases: A review on phytochemistry, pharmacology and toxicology. Journal of Integrative Medicine, 2022, 20(4): 292-304.
[2] Jia-yi Zhao, Jin Pu, Jian Fan, Xin-yu Feng, Jian-wen Xu, Rong Zhang, Yan Shang. Tanshinone IIA prevents acute lung injury by regulating macrophage polarization. Journal of Integrative Medicine, 2022, 20(3): 274-280.
[3] Peter Bablis, Henry Pollard, Anthony L. Rosner. Stress reduction via neuro-emotional technique to achieve the simultaneous resolution of chronic low back pain with multiple inflammatory and biobehavioural indicators: A randomized, double-blinded, placebo-controlled trial. Journal of Integrative Medicine, 2022, 20(2): 135-144.
[4] Victor Abou Nehmi Filho, Gilson Masahiro Murata, Ruan Carlos Macêdo de Moraes, Gabriely Cristina Alves Lima, Danielle Araujo de Miranda, Katrin Radloff, Raquel Galvão Figuerêdo Costa, Joyce de Cassia Rosa de Jesus, Jéssica Alves De Freitas, Nayara Izabel Viana, Ruan Pimenta, Katia Ramos Moreira Leite, José Pinhata Otoch, Ana Flávia Marçal Pessoa. A novel supplement with yeast β-glucan, prebiotic, minerals and Silybum marianum synergistically modulates metabolic and inflammatory pathways and improves steatosis in obese mice. Journal of Integrative Medicine, 2021, 19(5): 439-450.
[5] Na Zhi, Qian Mo, Shuo Yang, Yuan-xing Qin, Hao Chen, Zeng-guang Wu, Cai-hong Lan, Jun Zhang, Yin-long Li. Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report. Journal of Integrative Medicine, 2021, 19(2): 185-190.
[6] Swatantra Kumar, Vimal K Maurya, Debadatta Nayak, Anil Khurana, Raj K Manchanda, Srinivasulu Gadugu, Madan LB Bhatt, Shailendra K Saxena. Calcarea carbonica treatment rescues lipopolysaccharide-induced inflammatory response in human mononuclear cells via downregulation of inducible cyclooxygenase pathway. Journal of Integrative Medicine, 2020, 18(5): 441-449.
[7] Uday P. Pratap, Hannah P. Priyanka, Karthik R. Ramanathan, Vishak Raman, Lalgi Hima, Srinivasan Thyagarajan. Noni (Morinda citrifolia L.) fruit juice delays immunosenescence in the lymphocytes in lymph nodes of old F344 rats. Journal of Integrative Medicine, 2018, 16(3): 199-207.
[8] Byung Hyuk Han, Yun Jung Lee, Jung Joo Yoon, Eun Sik Choi, Seung Namgung, Xian Jun Jin, Da Hye Jeong, Dae Gill Kang, Ho Sub Lee. Hwangryunhaedoktang exerts anti-inflammation on LPS-induced NO production by suppressing MAPK and NF-κB activation in RAW264.7 macrophages. Journal of Integrative Medicine, 2017, 15(4): 326-336.
[9] Anirudha A. Lande, Shirishkumar D. Ambavade, Uma S. Swami, Prafulla P. Adkara Prashant D. Ambavade, Arun B. Waghamare. Saponins isolated from roots of Chlorophytum borivilianum reduce acute and chronic inflammation and histone deacetylase. Journal of Integrative Medicine, 2015, 13(1): 25-33.
[10] Benjamin Perry, Junzeng Zhang, Tarek Saleh, Yanwen Wang. Liuwei Dihuang, a traditional Chinese herbal formula, suppresses chronic inflammation and oxidative stress in obese rats. Journal of Integrative Medicine, 2014, 12(5): 447-454.
[11] Xin-fang Zhang, Ji Zhu, Wen-ye Geng, Shu-jun Zhao, Chuan-wei Jiang, Sheng-rong Cai, Miao Cheng, Chuan-yun Zhou, Zi-bing Liu. Electroacupuncture at Feishu (BL13) and Zusanli (ST36) down-regulates the expression of orexins and their receptors in rats with chronic obstructive pulmonary disease. Journal of Integrative Medicine, 2014, 12(5): 417-424.
[12] Jian-sheng Li, Ya Li, Su-yun Li, Yuan-yuan Wang, Li Deng, Yan-ge Tian, Su-li Jiang , Ying Wang. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease. Journal of Chinese Integrative Medicine, 2012, 10(9): 1039-1048.
[13] Bamidele Victor Owoyele, Omosunkanmi Toyin Adenekan, Ayodele Olufemi Soladoye. Effects of honey on inflammation and nitric oxide production in Wistar rats. Journal of Chinese Integrative Medicine, 2011, 9(4): 447-452.
[14] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013.
[15] Wen-xiang Zhou, Wen-bin Zheng, Xiao-mei Huang, Ying Zhang, Xiang-zhi Nie, Hong-bing Li, Da He, Lan-qian Xie. Effects of oxymatrine on microinflammatory state in patients undergoing continuous hemodialysis: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2009, 7(8): 736-740.
Full text



[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239